Global Rheumatoid Arthritis Competitor Landscape Report

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
156
Global Rheumatoid Arthritis Competitor Landscape Report 2018: Ongoing Development Activities and Analysis of Current & Potential Future Product Positioning

Dublin, Feb. 04, 2019 (GLOBE NEWSWIRE) -- The "Competitor Landscape: Rheumatoid Arthritis" report has been added to ResearchAndMarkets.com's offering. "Competitor Landscape: Rheumatoid Arthritis", briefings contain evaluations of ongoing development activities within the Rheumatoid Arthritis (RA) disease market, together with analysis of current & potential future product positioning. Key Highlights from the report

  • If the results of the Phase II MANTA safety trial are required by the FDA prior to filing for regulatory approval of filgotinib for Rheumatoid Arthritis (RA), this could delay US approval by 2 years.
  • Given that the Phase II NCT03241108 trial is limited to 90 patients in the EU, it is likely that NovImmune will need to initiate a second Phase II trial with a larger number of patients, including US patients, prior to proceeding with a Phase III program for NI-0101 in Rheumatoid Arthritis (RA).
  • The Phase II trial assessing the immunogenicity and safety of Zostavax in Rheumatoid Arthritis (RA) patients using abatacept, if positive, is likely to boost physician opinion of abatacept's safety profile in Rheumatoid Arthritis (RA), and reduce potential physician concerns that the use of abatacept may negatively impact the effectiveness of some immunizations, as suggested by its US FDA label.

Landscape Updates

  • Order of Entry' analysis, detailing timeline forecasts for each drug in Phase II development or higher.
  • Timeline forecasts for each approved product's lifecycle management initiatives.
  • Market Entry' & Direction of Travel' positioning analysis for pipeline & currently approved therapies.

Pipeline Landscape

  • An overview of pipeline candidates, containing snapshots of current development status.
  • Expected drug-specific events & milestones until YE 2019.

Approved Product Landscape

  • An overview of pipeline candidates, containing snapshots of current development status.
  • Expected drug-specific events & milestones until YE 2019.

Appendix

  • Current early stage RA pipeline & candidate Watch List',
  • Timeline assumptions, including standard assumptions & drug-specific assumptions.

Scope

  • The briefing is based on Sociable Pharma's analysis of clinical trial data from company announcements (press releases, earnings calls) and clinical trial databases (clinicaltrials.gov)
  • Sociable Pharma applies disease & drug specific assumptions in order to forecast US & EU approvals for drugs in Phase II development, or higher - these are outlined in the report Appendix
  • Forecasts are presented in pipeline forecast figures & detailed tables
  • Market Entry' & Direction of Travel' positioning analysis for pipeline & currently approved therapies is also provided.

Reasons to Buy

  • Provides details on forecast US & EU approvals for pipeline drugs in Phase II development or higher
  • Includes potential positioning strategies that companies may adopt for their novel assets once they are approved & launched in the market
  • Reviews ongoing lifecycle management strategies for existing players in the market
  • A detailed methodology allows you to understand the forecast assumptions made, enabling cross comparison with your own internal forecasts.

Key Topics Covered:

  1. Introduction to Sociable Pharma's Competitor Landscape'
  2. Executive Summary
  3. Key Events & Landscape Updates
  4. Landscape Updates
  5. Order of Entry
  6. Key Competitor Market Entry Strategies
  7. Lifecycle Development
  8. Key Competitor Direction of Travel'
  9. Pipeline Landscape
  10. Pipeline Summary
  11. Approved Product Development Landscape
  12. Lifecycle Development
  13. Appendix

Companies Mentioned

  • AbbVie
  • Abivax
  • Ablynx
  • ACEA Biosciences
  • Acerta Pharma
  • Akari Therapeutics
  • Akros Pharma
  • Amgen
  • Asana Biosciences
  • Astellas
  • AstraZeneca
  • Bayer
  • Biocad
  • Bird Rock Bio
  • BMS
  • Boehringer Ingelheim
  • Can-Fite Biopharma
  • Celgene
  • Chemo-Centryx
  • Cyclacel
  • Daichii Sankyo
  • Eddingpharm
  • Eisai
  • Galapagos
  • Genentech
  • Gilead
  • GSK
  • Hanmi
  • Hutchison Medi Pharma
  • Innate Pharma
  • Innocare Pharma
  • Istesso
  • Janssen
  • Japan Tobacco
  • Jiangsu HengRui
  • Lilly
  • Lupin
  • MacroGenics
  • MedImmune
  • Merck KGaA
  • Mesoblast
  • Momenta
  • MorphoSys
  • Morphotek
  • MSD
  • Nektar Therapeutics
  • Novartis
  • NovImmune
  • Noxopharm
  • Nuevolution
  • Oscotec
  • OSE Immuno Therapeutics
  • Pfizer
  • Philogen
  • Principia Biopharma
  • Protalex
  • Reata Pharmaceuticals
  • Regen BioPharma
  • Regeneron
  • Rigel Pharmaceuticals
  • Roche
  • Rottapharm Biotech
  • R-Pharm
  • Sanofi
  • Sareum
  • Swedish Orphan Biovitrum
  • Taiho
  • Taisho
  • Takeda
  • TiGenix
  • UCB
  • Valeant
  • Viela Bio
  • Vitaeris
  • WuXi
  • Xencor

For more information about this report visit https://www.researchandmarkets.com/research/z...atoid?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Allergy and Immunology

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leatt Gears Up for Q3 Results Conference Call

Updated Category News Views 106

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Continue Reading
Why Retaining Wall Drainage Can’t Be an Afterthought

Updated Category News Views 47

The overlooked hero in wall longevity People might think building a retaining wall is just stacking stones or pouring concrete, but that's only part of the story. According to Justin Hundich, our go-to guy on landscape and drainage matters, there's way more at play than meets the eye. If you ignore drainage, you're steaming toward disaster, my friend—no two ways about...

Continue Reading
Painter Capri: Comfort Revolution or Just Hype?

Updated Category News Views 20

A New Hope for Painters' Comfort? Alright, here we go. Some folks out there in the land of ladders and rollers have had it with wearing uncomfortable, stifling work gear every day. Enter the PAINTER CAPRI. Designed by an inventive spirit from Homer Glen, Illinois, these pants aim to be both breathable and functionally sound—for painters, electricians, and other gritty...

Continue Reading
Global Museum of Illusions Comes to San Francisco

Updated Category News Views 78

Illusions on Market Street The Global Museum of Illusions, the fast-growing sensation in private museums, is setting its sights on San Francisco with a new location opening on Market Street this November 13. They're dangling a juicy 50% off presale ticket offer for the early birds. A Mind-Bending Experience This museum isn't your run-of-the-mill art gallery or historical...

Continue Reading
Orthodontic Treatment: Timelines and Expert Insights

Updated Category News Views 62

Getting Straight to the Point: Orthodontic Timelines Remember that time your teen self thought braces would be over in a flash? Yeah, well, Dr. Judith Okun might have a few words on that. When it comes to braces, you better buckle up for the long haul. Most folks are looking at a solid two years, give or take. No magic shortcuts here, just solid orthodontic science. The...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 233

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
EZ MOUSE Revolutionizes Multi-Device Computing Control

Updated Category News Views 74

A New Dawn for Multi-Device Users Sometimes, the best ideas are born from sheer frustration. Take this EZ MOUSE invention, for example. Some creative soul from Sun Prairie, Wisc. had enough of juggling multiple computer mice for their array of desktops and laptops. In response, they hatched the idea for a patent-pending gadget that aims to streamline operations across...

Continue Reading
Specialty1 Partners: Top Workplaces Triumph in 2026

Updated Category News Views 34

Employees Crown Specialty1 Partners a Workplace Gem There are only a few things in the business world sweeter than being named a Top Workplace, and flying that banner proudly is exactly what Specialty1 Partners gets to do. Named a winner by the Houston Chronicle in 2026, this recognition is no regular accolade. It's built on the raw honesty that employee surveys provide,...

Continue Reading
Mesh Security Bolsters Team with Five Cybersecurity Experts

Updated Category News Views 87

New Blood in Cybersecurity: Mesh's Strategic Moves Ever felt like the cybersecurity world is in a constant game of catch-up? You're not wrong. In today's digital battleground, companies don't just need more tools—they need collective wisdom to bind it all together. And it seems like Mesh Security just caught onto that notion, stacking their deck with five new...

Continue Reading
Outpace SEO Claims Impressive 3.7x Client ROI Boost

Updated Category News Views 53

Outpace SEO's Bold Promise: A Data-Driven Success The SEO game isn't for the faint-hearted. You either step up or get left behind. Outpace SEO, hailing from Oklahoma City, has decided to set their own rules with a boastful claim of a 3.7x return on investment (ROI) for their clients. That kind of promise sets the bar high, and it's tied to their data-driven approach to...

Continue Reading

Top 5 Most Recently Viewed Articles

Piramal Pharma's Sustainability Report: A Commitment to the Future

Updated Category News Views 149

Piramal Pharma's Commitment to Sustainability Piramal Pharma Limited (PPL) has recently released its latest annual Sustainability Report for the financial year 2023-24, themed 'Building Resilience for a Sustainable Tomorrow.' This marks the third independent report issued by the company, reinforcing its dedication to sustainability across various operational fronts....

Continue Reading
ClearSign Technologies Corp Secures Flare Project Order

Updated Category News Views 81

ClearSign Technologies Corporation Secures Flare Project Order ClearSign Technologies Corporation (NASDAQ: CLIR) has successfully received a purchase order for a flare system, which marks another advancement in their commitment to providing innovative solutions for industrial combustion and emissions reduction. This order is connected to an energy company and is part of...

Continue Reading
Xtrackers ETFs Adjust Index Names for Better Clarity

Updated Category News Views 166

Xtrackers ETFs Adjust Index Names for Better Clarity Xtrackers (IE) plc is making some significant changes to the names of their exchange-traded funds (ETFs). This update was recently communicated by MSCI Limited, the index administrator. The adjustments are part of an initiative to simplify and streamline the naming of their reference indices. Changes in ETF Index Naming...

Continue Reading
Melania Trump's Message to Putin Aids Ukrainian Child Reunifications

Updated Category News Views 317

Melania Trump's Efforts in Child Reunification In a heartfelt address, former First Lady Melania Trump shared details about her direct communication with Russian President Vladimir Putin, which she claims has been instrumental in reuniting eight Ukrainian children separated from their families due to the ongoing conflict. Melania emphasized the urgency of protecting...

Continue Reading
Strengthening Ties: China-Africa Economic Forum Highlights

Updated Category News Views 137

Strengthening Economic Ties Between China and Africa The 2024 council meeting of the China-Africa Joint Chamber of Commerce and Industry took place recently, focusing on enhancing trade and economic partnerships. This event was a notable gathering aimed at fostering collaboration between Chinese and African representatives across various sectors. Participants at the...

Continue Reading